BIO 2015 Dispatches: Payer Considerations, Engagement Key To Biopharma Success
This article was originally published in The Pink Sheet Daily
Executive Summary
DVG Life Sciences' Coos de Graaf points to turf battles and differing objectives between R&D and market access divisions as another problem area for biopharma companies.